Antiandrogen Market Report

Europe Antiandrogen Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 16, 2019
  • PAGES：173
  • REPORT CODE：GMM325301
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Antiandrogen market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Antiandrogen Market Segmentations:

    By Player:

    • Immunomedics

    • Pfizer

    • Novartis AG

    • Genentech

    • Abbott Laboratories

    • Indevus Pharmaceuticals

    • GlaxoSmithKline

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antiandrogen Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Antiandrogen Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Antiandrogen Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Antiandrogen Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Antiandrogen Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Antiandrogen Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Antiandrogen Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Antiandrogen Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antiandrogen by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Antiandrogen Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antiandrogen by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antiandrogen for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Antiandrogen for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Antiandrogen for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Antiandrogen Production Analysis by Top Regions

    • 5.2 Europe Antiandrogen Consumption Analysis by Top Regions

    • 5.3 Europe Antiandrogen Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.3 France Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Production, Import, Consumption and Export Analysis

    6 Product Circulation of Antiandrogen Market among Top Countries

    • 6.1 Top 5 Export Countries in Antiandrogen Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Antiandrogen Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Antiandrogen Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Antiandrogen Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Antiandrogen Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Antiandrogen Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Antiandrogen Landscape Analysis

    • 7.1 Germany Antiandrogen Landscape Analysis by Major Types

    • 7.2 Germany Antiandrogen Landscape Analysis by Major End-Users

    8. UK Antiandrogen Landscape Analysis

    • 8.1 UK Antiandrogen Landscape Analysis by Major Types

    • 8.2 UK Antiandrogen Landscape Analysis by Major End-Users

    9. France Antiandrogen Landscape Analysis

    • 9.1 France Antiandrogen Landscape Analysis by Major Types

    • 9.2 France Antiandrogen Landscape Analysis by Major End-Users

    10. Italy Antiandrogen Landscape Analysis

    • 10.1 Italy Antiandrogen Landscape Analysis by Major Types

    • 10.2 Italy Antiandrogen Landscape Analysis by Major End-Users

    11. Spain Antiandrogen Landscape Analysis

    • 11.1 Spain Antiandrogen Landscape Analysis by Major Types

    • 11.2 Spain Antiandrogen Landscape Analysis by Major End-Users

    12. Poland Antiandrogen Landscape Analysis

    • 12.1 Poland Antiandrogen Landscape Analysis by Major Types

    • 12.2 Poland Antiandrogen Landscape Analysis by Major End-Users

    13. Russia Antiandrogen Landscape Analysis

    • 13.1 Russia Antiandrogen Landscape Analysis by Major Types

    • 13.2 Russia Antiandrogen Landscape Analysis by Major End-Users

    14. Switzerland Antiandrogen Landscape Analysis

    • 14.1 Switzerland Antiandrogen Landscape Analysis by Major Types

    • 14.2 Switzerland Antiandrogen Landscape Analysis by Major End-Users

    15. Turkey Antiandrogen Landscape Analysis

    • 15.1 Turkey Antiandrogen Landscape Analysis by Major Types

    • 15.2 Turkey Antiandrogen Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Landscape Analysis by Top Countries

      • 16.3.1 Denmark Antiandrogen Market Volume and Growth Rate

      • 16.3.2 Finland Antiandrogen Market Volume and Growth Rate

      • 16.3.3 Norway Antiandrogen Market Volume and Growth Rate

      • 16.3.4 Sweden Antiandrogen Market Volume and Growth Rate

      • 16.3.6 Iceland Antiandrogen Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Landscape Analysis by Top Countries

      • 17.3.1 Belgium Antiandrogen Market Volume and Growth Rate

      • 17.3.2 Netherlands Antiandrogen Market Volume and Growth Rate

      • 17.3.3 Luxembourg Antiandrogen Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Landscape Analysis by Top Countries

      • 18.3.1 Estonia Antiandrogen Market Volume and Growth Rate

      • 18.3.2 Latvia Antiandrogen Market Volume and Growth Rate

      • 18.3.3 Lithuania Antiandrogen Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Immunomedics

      • 19.1.1 Immunomedics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Pfizer

      • 19.2.1 Pfizer Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Novartis AG

      • 19.3.1 Novartis AG Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Genentech

      • 19.4.1 Genentech Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Abbott Laboratories

      • 19.5.1 Abbott Laboratories Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Indevus Pharmaceuticals

      • 19.6.1 Indevus Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 GlaxoSmithKline

      • 19.7.1 GlaxoSmithKline Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 74 Figures and 113 Tables)

    • Figure Product Picture

    • Figure Europe Antiandrogen Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Antiandrogen Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Antiandrogen Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Antiandrogen Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Antiandrogen Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Antiandrogen Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure UK Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure France Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Antiandrogen Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Antiandrogen Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Antiandrogen

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antiandrogen by Different Types from 2014 to 2026

    • Table Consumption Share of Antiandrogen by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Antiandrogen by Different End-Users from 2014 to 2026

    • Table Consumption Share of Antiandrogen by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Antiandrogen Production by Major Regions

    • Table Europe Antiandrogen Production Share by Major Regions

    • Figure Europe Antiandrogen Production Share by Major Countries and Regions in 2014

    • Table Europe Antiandrogen Consumption by Major Regions

    • Table Europe Antiandrogen Consumption Share by Major Regions

    • Table Germany Antiandrogen Production, Import, Consumption and Export Analysis

    • Table UK Antiandrogen Production, Import, Consumption and Export Analysis

    • Table France Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Italy Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Spain Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Poland Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Russia Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Switzerland Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Turkey Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Antiandrogen Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Antiandrogen Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Antiandrogen Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Antiandrogen Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Antiandrogen Consumption by Types from 2014 to 2026

    • Table Germany Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Germany Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Germany Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table UK Antiandrogen Consumption by Types from 2014 to 2026

    • Table UK Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table UK Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table UK Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table France Antiandrogen Consumption by Types from 2014 to 2026

    • Table France Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table France Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table France Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Italy Antiandrogen Consumption by Types from 2014 to 2026

    • Table Italy Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Italy Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Italy Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Spain Antiandrogen Consumption by Types from 2014 to 2026

    • Table Spain Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Spain Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Spain Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Poland Antiandrogen Consumption by Types from 2014 to 2026

    • Table Poland Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Poland Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Poland Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Russia Antiandrogen Consumption by Types from 2014 to 2026

    • Table Russia Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Russia Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Russia Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Antiandrogen Consumption by Types from 2014 to 2026

    • Table Switzerland Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Switzerland Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Switzerland Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Antiandrogen Consumption by Types from 2014 to 2026

    • Table Turkey Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Turkey Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Turkey Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Antiandrogen Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Antiandrogen Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Antiandrogen Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Antiandrogen Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Immunomedics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics

    • Figure Sales and Growth Rate Analysis of Immunomedics

    • Figure Revenue and Market Share Analysis of Immunomedics

    • Table Product and Service Introduction of Immunomedics

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Genentech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech

    • Figure Sales and Growth Rate Analysis of Genentech

    • Figure Revenue and Market Share Analysis of Genentech

    • Table Product and Service Introduction of Genentech

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Indevus Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals

    • Table Product and Service Introduction of Indevus Pharmaceuticals

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US